Hemab Therapeutics Holdings Inc (COAG) saw its stock price soar 50.00% intraday on Friday, marking a dramatic debut on the public market.
The surge follows the company's announcement that it priced its initial public offering of 16.8 million shares at $18 per share, raising $301.5 million. Shares began trading on the Nasdaq Global Select Market on Friday under the ticker "COAG," with the first-day rally reflecting strong investor demand for the newly listed stock.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.